secwatch.observer — SEC 8-K summary
======================================

Issuer:     PERRIGO Co plc (PRGO)
CIK:        0001585364
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001585364-25-000153
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perrigo Q3 adj EPS $0.80 flat YoY; cuts FY25 guide; starts infant formula review
--------------------------------------------------------------------------------

- Q3 net sales $1.04B (-4.1% YoY); adj EPS $0.80 vs $0.81; reported EPS $0.09 vs -$0.13.
- FY25 outlook lowered: net sales growth -2.5% to -3.0%, adj EPS $2.70-$2.80 (5%-9% YoY growth).
- Initiates strategic review of infant formula business; continues oral care review; Dermacosmetics sale on track for Q1 2026.
- OTC store brand gained dollar, unit, and volume share in 5 of 7 categories despite soft market.
- YTD adj operating income up 9.8% to $455M; benefits from Project Energize and Supply Chain Reinvention.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585364/000158536425000153/0001585364-25-000153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585364/000158536425000153/prgo-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001585364-25-000153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer